Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OBIO stock hub

Orchestra BioMed Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OBIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

241.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

OBIO

In the news

Latest news · OBIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-109.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-50.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OBIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001814114
Company name	Orchestra BioMed Holdings, Inc.
Country	United States
Country code	US
Cusip	68572M106
Employees	86
Employees Change	16%
Employees Change Percent	22.86
Enterprise value	$151.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US68572M1062
Last refreshed	2026-05-10
Market cap	$241.9M
Market cap category	Micro-Cap
Price	$4.04
Price currency	USD
Rev Per Employee	389,325.58x
Sector	Healthcare
Sic	3841
Symbol	OBIO
Website	https://www.orchestrabiomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-21.89%
EV Sales Forward	98.24x
EV/Sales	4.52x
FCF yield	-20.44%
P/B ratio	4.3x
P/S ratio	7.23x
PS Forward	157.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-154.73%
EBITDA Margin	-153.75%
Gross margin	99.43%
Gross Profit	$33.3M
Gross Profit Growth	1,267.79%
Gross Profit Growth Q	15,728.72%
Gross Profit Growth3 Y	115.6%
Net Income	$-53M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-157.4%
Profit Margin	-157.4%
Profit Per Employee	$-615,756
ROA	-33.9
Roa5y	-40.95
ROCE	-52.8
ROE	-109.4
ROIC	-50.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	64.28%
Cagr3y	-37.95%
Cagr5y	-17.26%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	1,169.22x
Revenue Growth Q	12,120.16x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	111.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.35
Assets	$114.9M
Cash	$106.5M
Current Assets	$107.9M
Current Liabilities	$16.7M
Debt	$16M
Debt Equity	$0.25
Equity	$63.4M
Interest Coverage	-27.27
Liabilities	$51.5M
Long Term Assets	$6.9M
Long Term Liabilities	$34.7M
Net Cash	$90.6M
Net Cash By Market Cap	$37.43
Net Cash Growth	80.09%
Net Debt Equity	$-1.43
Tangible Book Value	$53.6M
Tangible Book Value Per Share	$0.94
WACC	7.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.45
Inventory Turnover	0.79
Net Working Capital	$-14.6M
Quick ratio	6.37
Working Capital	$91.2M
Working Capital Turnover	$0.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	64.23%
200-day SMA	3.8
3Y total return	-76.12%
50-day SMA	4.32
50-day SMA vs 200-day SMA	50over200
5Y total return	-61.23%
All Time High	23.39
All Time High Change	-82.73%
All Time High Date	2023-04-03
All Time Low	2.2
All Time Low Change	83.64%
All Time Low Date	2025-09-24
ATR	0.23
Beta	0.52
Beta1y	1.38
Beta2y	1.91
Ch YTD	-2.65
High	4.12
High52	5.42
High52 Date	2025-11-26
High52ch	-25.52%
Low	3.9
Low52	2.2
Low52 Date	2025-09-24
Low52ch	83.64%
Ma50ch	-6.52%
Price vs 200-day SMA	6.4%
RSI	45.72
RSI Monthly	46.2
RSI Weekly	49.59
Sharpe ratio	0.98x
Sortino ratio	1.66
Tr YTD	-2.65
Tr1m	-5.16%
Tr1w	1.76%
Tr3m	3.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$20
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.43
Earnings Revenue Estimate	512,664x
Earnings Revenue Estimate Growth	-40.94x
Operating Income	$-51.8M
Operating margin	-154.7
Price target	$14.25
Price Target Change	$253
Price Target Change Top	$395

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,554,818%
Float Percent	56.04%
Net Borrowing	20,000,000
Shares Insiders	2.61%
Shares Institutions	19.47%
Shares Out	59,880,715
Shares Qo Q	18.74%
Shares Yo Y	29.67%
Short Float	2.64%
Short Ratio	4.76
Short Shares	1.48

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-61.4M
Average Volume	191,991.85x
Bv Per Share	0.94
CAPEX	$-489,000
Ch1m	-5.16
Ch1w	1.76
Ch1y	64.23
Ch3m	3.33
Ch3y	-76.12
Ch5y	-61.23
Ch6m	6.04
Change	2.8%
Change From Open	1.25
Close	3.93
Days Gap	1.53
Depreciation Amortization	327,000
Dollar Volume	796,324.4
Earnings Date	2026-05-11
Earnings Time	amc
EBIT	$-51.8M
EBITDA	$-51.5M
EPS	$-1.11
F Score	5
FCF	$-49.5M
FCF EV Yield	-32.67x
FCF Per Share	$-0.83
Financing CF	88,333,000
Fiscal Year End	December
Founded	2,017
Investing CF	-26,941,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	4.17
Ma150ch	-3.16%
Ma20	4.17
Ma20ch	-3.09%
Net CF	12,429,000
Next Earnings Date	2026-05-22
Open	3.99
Optionable	Yes
Position In Range	64.22
Post Close	4.04
Postmarket Change Percent	-0.12
Postmarket Price	$4.04
Ppne	3,211,000
Price Date	2026-05-08
Ptbv Ratio	4.52
Relative Volume	1.03x
Revenue	33,482,000x
SBC By Revenue	35.77x
Share Based Comp	11,978,000
Tr6m	6.04%
Us State	Pennsylvania
Volume	197,110
Z Score	-2.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OBIO pay a dividend?

Capital-return profile for this ticker.

Performance

OBIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OBIO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.5%

Float: +56.0% of shares outstanding

Insider ownership

+2.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OBIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.7

Neutral momentum band

Price vs 200-day MA

+6.4%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

0.98

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OBIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OBIO stock rating?

Orchestra BioMed Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OBIO analysis?

The full report lives at /stocks/OBIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OBIO?

The latest report frames OBIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OBIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.